Compare Perdana Karya Perkasa Tbk (PKPK) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Perdana Karya Perkasa Tbk vs Organon Pharma Indonesia Tbk. — how do they compare? Perdana Karya Perkasa Tbk trades at Rp4,450 (market cap 5.34T, 1.08M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Perdana Karya Perkasa Tbk is far larger — about 51.1× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| PKPK | SCPI | |
|---|---|---|
Market Cap | 5.34T | 104.4B |
Volume | 1.08M | — |
Lot | 10.75K | — |
Turnover | 4.78B | — |
Average Price | 4,443.43 | — |
Value | 4.78B | — |
Indicative Equilibrium Price | 4,450 | — |
Indicative Equilibrium Volume | 781 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Perdana Karya Perkasa Tbk
PT Perdana Karya Perkasa (the company) was established under its original name of PT Perdana Karya Kaltim on Dec 7, 1983 then changed to PT Perdana Karya Perkasa based on Notaries Deed dated Jun 30, 2006 and the deed of establishment was approved by the the Ministry of Justice dated Aug 9, 2006. The Company articles of association has been amended several times, most recently by notarial deed No. 46 of Marina Soewana, S.H., dated Sep 28, 2006, concerning among others, the change in the Company name and public offering
Read more on PKPK →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
